Search

Your search keyword '"Castell, C."' showing total 120 results

Search Constraints

Start Over You searched for: Author "Castell, C." Remove constraint Author: "Castell, C." Database Unpaywall Remove constraint Database: Unpaywall
120 results on '"Castell, C."'

Search Results

3. CO130 Dyspnea and Health-Related Quality of Life in Patients with Persistent Symptoms after at Least Six Months of Hospital Discharge Due to COVID-19

5. Age-period-cohort modelling of type 1 diabetes incidence rates among children included in the EURODIAB 25-year follow-up study

6. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

9. Guías de práctica clínica basadas en la evidencia para el manejo de la sedoanalgesia y delirium en el paciente adulto críticamente enfermo

10. Evidence-based clinical practice guidelines for the management of sedoanalgesia and delirium in critically ill adult patients

11. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

19. AB1206-HPR Adaptation into spanish of the scleroderma health assesment questionnaire (S-HAQ)

22. Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

23. Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

24. Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

25. Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

26. Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

27. Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989-2008: little short-term influence of sunshine hours or average temperature

28. Guía de práctica clínica basada en la evidencia para el manejo de la sedoanalgesia en el paciente adulto críticamente enfermo

29. Clinical practice guidelines for evidence-based management of sedoanalgesia in critically ill adult patients

30. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study

33. Mediterranean Diet Adherence in Individuals with Prediabetes and Unknown Diabetes: The Di@bet.es Study

34. Iodine intake in the adult population. Di@bet.es study

36. Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase

37. Evaluation of Health-Related Quality of Life according to Carbohydrate Metabolism Status: A Spanish Population-Based Study (Di@bet.es Study)

38. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study

41. Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data

43. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989

50. Variation by age group and seasonally at diagnosis of childhood IDDM in Europe

Catalog

Books, media, physical & digital resources